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Objectives: We sought to review the clinical sequelae and imaging manifestations of thoracic aortic endograft
collapses and infoldings and to evaluate minimally invasive methods of repairing such collapses.
Methods: Two hundred twenty-one Gore endografts (Excluder, TAG; W. L. Gore & Associates, Inc, Flagstaff,
Ariz) were deployed in 145 patients for treatment of pathologies including aneurysms and pseudoaneurysms,
dissections, penetrating ulcers, transections, fistulae, mycotic aneurysms, and neoplastic invasions in 6 different
prospective trials at a single institution from 1997 to 2007. Device collapses and infoldings were analyzed
retrospectively, including review of anatomic parameters, pathologies treated, device sizing and selection, clinical
sequelae, methods of repair, and outcome.
Results: Six device collapses and infoldings were identified. Oversized devices placed into small-diameter aortas
and imperfect proximal apposition to the lesser curvature were seen in all proximal collapses, affecting patients
with transections and pseudoaneurysms. Infoldings in patients undergoing dissection represented incomplete ini-
tial expansion rather than delayed collapse. Delayed collapse occurred as many as 6 years after initial successful
deployment, apparently as a result of changes in the aortic configuration from aneurysmal shrinkage. Clinical
manifestations ranged from life-threatening ischemia to complete lack of symptoms. Collapses requiring therapy
were remedied percutaneously by bare stenting or in one case by branch vessel embolization.
Conclusions:Use of oversized devices in small aortas carries a risk of device failure by collapse, which can occur
immediately or after years of delay. When clinically indicated, percutaneous repair can be effectively performed.Since its original introduction into clinical trials in 1997 as
the Thoracic Excluder and its subsequent redesign in 2003
as the TAG, the Gore thoracic endograft device (W. L.
Gore & Associates, Inc, Flagstaff, Ariz) has received CE
Marking and US Food and Drug Administration (FDA) Pre-
market Approval for treatment of aneurysms of the descend-
ing thoracic aorta, and thousands of devices have been
implanted worldwide. Indications and anatomic inclusion
criteria are explicitly specified,1 but numerous trials and
off-label uses of the devices have pushed beyond these es-
tablished boundaries. Applications in situations outside of
the physical conditions for which the device was designed
and bench tested could result in device failure. Several
case reports have described partial or total collapse of
TAG devices, all leading to further major intervention.2-12
We describe our experience with 6 recognized device col-
lapses and infoldings, review the potential causative factors
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tive and minimally invasive treatment options.
MATERIALS AND METHODS
All patient data were handled in accordance to Health Insurance Portabil-
ity and Accountability Act regulations. All 6 protocols in which patients
were enrolled were approved by the institutional review board.
From 1997 to July 2004, 136 Gore Thoracic Excluder devices were im-
planted into 87 patients at a single academic institution under 2 different
Gore-sponsored FDA trials and 1 Investigator-sponsored Investigational
Device Exemption (ISIDE) trial. From November 2003 to October 2007,
an additional 85 TAG devices were implanted into 58 patients in 3 different
Gore-sponsored trials and the continuation of the ISIDE. Device-related ad-
verse events were prospectively documented in the mandatory follow-up
protocols and retrospectively reviewed for this study.
RESULTS
Six device collapses and infoldings were documented,
including 3 acute collapses in patients treated for traumatic
injury of the aorta, 2 infoldings in patients with acute and
subacute aortic dissection, and 1 delayed collapse in a patient
treated for an anastomotic pseudoaneurysm (Table 1). The
delayed collapse involved a Thoracic Excluder more than
6 years after original deployment, and the other 5 involved
TAG devices.
Patient 1
A 23-year-old man presented to an outside hospital with
a complex bullet injury after an apparent attempted assaultrgery c August 2009
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CT ¼ computed tomographic
FDA ¼ US Food and Drug Administration
IFU ¼ Instructions for Use
ISIDE ¼ Investigator-sponsored Investigational
Device Exemption
LSCA ¼ left subclavian artery
PIT ¼ primary intimal tear
on his cervical spinal cord 1 day after his being released from
incarceration. The bullet transgressed his mastoid region,
mandible, and hyoid and lodged in his left thorax. Because
of a VI/VI bruit in his thorax, a computed tomographic
(CT) scan was performed, which showed a fistula from his
descending thoracic aorta extending cranially through the
mediastinum and into the left brachiocephalic vein, which
had been transgressed by the bullet. He was electively intu-
bated and transferred to our institution for treatment.
The patient was enrolled into the ISIDE. The proximal
and distal landing areas measured 21 and 19 mm in average
diameter, respectively. A 26 mm 3 10 cm TAG was de-
ployed over the aortic injury, intentionally covering the ori-
gin of the left subclavian artery (LSCA). Postdeployment
plasty was performed by using a compliant trilobed balloon
(Gore), and the proximal end of the device appeared well ap-
posed to the aortic wall without a substantial ‘‘bird beak’’
(Table 2).13
The bruit resolved but returned to III/VI severity 3 days
later. A chest radiograph showed distortion of the endograft,
and a CT angiogram confirmed partial collapse of the prox-
imal 90% with a C-shaped cross-section, which was
concave toward the aortic lesser curve (Figure 1). At angio-
graphic reintervention, the TAG was easily re-expanded
with an angioplasty balloon but collapsed again immediatelyThe Journal of Thoracic and Con deflation of the balloon. Two balloon-expandable stents
(Palmaz XL 3110, Genesis XD 3910; Cordis/J&J, Warren,
NJ) were deployed within the proximal and mid endograft,
respectively, and dilated to 22 mm in diameter. Follow-up
radiographs and CT angiograms showed patency of the en-
dograft and elimination of the fistula. The patient was dis-
charged 5 days after bare stent placement but was quickly
lost to follow-up (Table 3).
Patient 2
A 44-year-old man experienced polytrauma from amotor-
cycle accident, including subarachnoid hemorrhage, grade 3
splenic laceration, displaced femoral fracture, and multiple
rib fractures. The proximal and distal landing areas mea-
sured 24 and 20 mm in average diameter, respectively. He
was enrolled in the ISIDE, and a 26 mm 3 10 cm TAG
was deployed over a Gavant grade 3 transection at the isth-
mus.14 An 18-mm length of the proximal device did not ap-
pose the aortic wall in the lesser curvature, despite repeated
balloon plasty.
A follow-up chest radiograph on postprocedure day 3
showed collapse, but by the time the radiograph was inter-
preted, the patient had undergone general anesthesia for
orthopedic fixation. Intraoperatively, the patient became an-
uric with a creatinine value of 2.1 mg/dL, acidotic with a pH
of 7.24 and a serum bicarbonate value of 18 mEq/L, all new
abnormalities since the previous day. Immediately after
completion of orthopedic fixation, the patient underwent
angiographic analysis, which revealed a 30 mm Hg mean
gradient across the collapsed endograft. The collapse was
repaired with a Palmaz 3110 stent dilated to 22 mm in diam-
eter. A small thrombus was evidently extruded into the left
subclavian artery by the stent deployment, requiring throm-
bectomy with the AngioJet device (Possis, Minneapolis,
Minn). No evidence of stroke or left upper extremity ische-
mia was detected. Metabolic parameters normalized withinTABLE 1. Patient demographics
Patient
no.
Age at time of
treatment
(y) Sex Aortic pathology Comorbidities
1 23 M Traumatic arteriovenous
fistula from gunshot wound
Mandibular and hyoid fractures, respiratory failure
2 44 M Traumatic transection, motorcycle
accident
Subarachnoid hemorrhage, splenic laceration, fractures of femur and ribs
3 40 M Traumatic transection, motor vehicle
accident
Atlanto-occipital dislocation; epidural, subdural, subarachnoid,
and intraventricular hemorrhage; renal contusion; pulmonary
embolism; fractures of pelvis, scapula, and 11 ribs
4 19 M Acute type B dissection End-stage renal disease, hypertension, transplant nephrectomy
for chronic rejection
5 42 M Subacute type B dissection Hypertension, diabetes, acute renal failure
6 67 M Anastomotic pseudoaneurysm Prior thoracotomies 3 2 for repair of coarctation, history of rheumatic
fever with recurrent endocarditisardiovascular Surgery c Volume 138, Number 2 325
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DTABLE 2. Anatomy and device-related parameters
Patient
no.
Devices used
(mm diameter 3
cm length)
Proximal
landing zone
diameters
(at 2, 1, and
0 cm above
lesion; mm)*
Distal
landing zone
diameters
(at 0, 1, and
2 cm below
lesion; mm)*
Minimum
diameter in
treated segment
after
deployment
(mm)*
Balloon
plasty
performed
after
initial
placement
Length of lack
of apposition
of device to
proximal lesser
curvature (bird beak),
including flares (mm)
1 26 3 10 TAG 21, 20, 17 19, 19, 19 19 Yes 10
2 26 3 10 TAG 25, 24, 25 20, 20, 21 22 Yes 18
3 26 3 10 TAG 24, 23, 23 23, 24, 22 23 No 5
4 26 3 10 TAG 23, 22, 21 21, 20, 18 21 3 11 (16) No 0
5 34 3 15 TAG 29, 29, 32 25 3 7 (17)
23 3 7 (16)
18 3 10 (14)
21 3 16 (19) No 21
6 26 3 12.5,
26 3 7.5,
31 3 15,
26 3 7.5
Thoracic excluders
32 3 26 (29)
28 3 24 (26)
26 3 22 (24)
26, 26, 26 24 3 18 (21) Yes 21
*Where luminal cross-sections were not circular, they were assumed to be elliptical. Major and minor axes were measured, perimeter was calculated by using the method of
Ramanujan,13 and the approximate equivalent circular diameter was then calculated (shown in parentheses).2 days, and the patient has had no further aortic issues in 22
months of follow-up.
Patient 3
A 40-year-old man experienced polytrauma from a motor
vehicle accident, including atlanto-occipital dislocation;
subarachnoid, subdural, epidural, and intraventricular hem-
orrhage; renal contusion; pulmonary embolism; and frac-
tures of the pelvis, scapula, and 11 ribs. He was enrolled
in the ISIDE, and a 26 mm 3 10 cm TAG was deployed
over his grade 3 aortic transection at the isthmus. The prox-
imal and distal landing areas measured 23 and 23 mm
in average diameter, respectively. A 12-mm length of the
proximal device did not appose the aortic wall in the lesser
curvature but was not subjected to balloon plasty. Collapse
was diagnosed by means of chest radiography on postproce-
dure day 3, but the patient was still so acutely ill from asso-
ciated injuries that no suspicion was raised for collapse
based on clinical signs. The patient was brought to angio-
graphic reintervention on an emergency basis, where a 35
mm Hg mean gradient was measured. The proximal and
mid TAG were reinforced with 2 Palmaz 3110 stents dilated
to 25 and 23 mm in diameter, respectively. This patient has
been free of aortic issues in 31 months of follow-up.
Patient 4
A 19-year-old man with chronic hypertension presented
with acute chest and back pain and hypotension during he-
modialysis. He had previously undergone transplant ne-
phrectomy for chronic rejection caused by noncompliance
with immunosuppressive medications. CT scanning of the
chest revealed an acute type B dissection, with the primary326 The Journal of Thoracic and Cardiovascular Suintimal tear (PIT) located 7 cm distal to the origin of the
left subclavian artery. The proximal and distal landing areas
measured 22 and 18 mm in average diameter, respectively,
with a minimal true-lumen diameter of 17 mm in between.
He was enrolled in the ISIDE, with consent provided by
his guardians. A 26 mm 3 10 cm TAG was deployed over
the PIT, but the device landed approximately 20 mm distal
to the measured landing area, and the proximal end of the de-
vice landed in an area where the true lumenmeasured 17 mm
in diameter before device deployment. Balloon plasty was
avoided because of the presumed fragility of the dissection
flap.
Infolding of the proximal half of the endograft was dem-
onstrated by means of CT angiographic imaging 3 days later,
along with a moderate type I proximal fixation endoleak, al-
lowing continued opacification of the false lumen. In retro-
spect, the procedural fluoroscopic images suggested that
the proximal portion of the device never fully opened, con-
strained by the dissection flap. The patient’s family refused
to consent to additional treatment but partially complied
with the follow-up protocol. The endoleak resolved sponta-
neously within 6 months, and the false lumen thrombosed
and regressed completely, despite persistent infolding of
the proximal half of the endograft. In 17 months of fol-
low-up, the patient demonstrated no evidence of distal ische-
mic or embolic complications but died from complications
of end-stage renal failure.
Patient 5
A 42-year-old man with a history of hypertension pre-
sented twice to an outside hospital with abdominal and flank
pain but was discharged after brief and unremarkablergery c August 2009
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DFIGURE 1. A, Thoracic aortogram of a 23-year-old man with a gunshot wound that caused a large arteriovenous fistula extending from the proximal de-
scending thoracic aorta into the left brachiocephalic vein. B, The fistula was closed by means of placement of a 26 mm3 10 cm TAG over the aortic injuryThe Journal of Thoracic and Cardiovascular Surgery c Volume 138, Number 2 327
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Patient
no.
Interval
between initial
treatment and
collapse
Portion of
device
collapsed
Length
of collapse (cm)
Direction
of concavity
of collapse
Minimum
luminal
diameter(mm)
Clinical
signs and
symptoms
Secondary
procedures Outcome
1 3 d Proximal/mid 9 Toward lesser
curvature
25 3 15 (20) None Bare stent 3 2 Resolved
2 3 d Proximal/mid 8 Toward lesser
curvature
9 Anuria,
acidemia;
30 mm Hg
gradient
Bare stent,
subclavian
thrombectomy
Resolved
3 3 d Proximal/mid 8 Toward lesser
curvature
11 None; 35
mm Hg
gradient
Bare stent Resolved
4 3 d Proximal 5 Toward true lumen
(lesser
curvature)
21 3 11 (16) None None Type 1 leak
resolved,
device
remained
collapsed
5 4 d Mid/distal 9 Toward false
lumen (greater
curvature)
21 3 16 (19) None; no
pressure
gradient
Coil
embolization
of left
subclavian
artery and
right T8
intercostal
artery
Leak resolved,
stent graft
gradually
opened but
eroded through
flap
6 6.5 y Entire 7.5 Toward lesser
curvature
0 None None Stable but
collapsedexaminations. On his third visit to the hospital, a CT scan
was performed, showing a type B aortic dissection with
poor perfusion of the left kidney. He was intubated for respi-
ratory failure and transferred to our institution for care. The
intact aorta proximal to the dissection measured 31 mm in
diameter, but the true lumen was attenuated to an 18 3 10
mm crescent in the midthorax. He was enrolled in the ISIDE,
and a 34 mm3 15 cm TAGwas deployed distal to the origin
of the left common carotid artery, covering the PIT, which
extended into the origin of the intentionally covered
LSCA. The distal half of the endograft did not fully expand
after deployment, but balloon dilatation was avoided be-
cause of the risk of causing a secondary intimal tear. Angi-
ography revealed restored flow to the mesenteric branches,
and a bare stent was placed in the dissected left renal artery
to obliterate the nonreentrant false lumen.
A CT angiogram 4 days after the procedure revealed per-
sistent infolding of the distal half of the endograft, which328 The Journal of Thoracic and Cardiovascular Suwas concave toward the false lumen. In addition, there
was persistent early contrast opacification of the aortic false
lumen, as well as of the covered LSCA. Because the symp-
toms of distal ischemia had resolved, no reintervention was
performed before discharge.
In follow-up, the endoleak persisted, resulting in aneurys-
mal dilatation of the false lumen and an increase in total
aortic diameter from 38 to 52 mm within 9 months. At 11
months, the origin of the LSCA was coil embolized, with
coils extending from the true lumen of the LSCA across
the PIT into the false lumen of the aorta (Figure 2). This re-
sulted in thrombosis of the false lumen proximally but with
persistent filling distally through natural fenestrations and
drainage into bronchial and intercostal arteries. Because of
progressive false lumen enlargement in the patent segment
at 19 months, the largest of the intercostal arteries was coil
embolized, eventually resulting in complete thrombosis of
the thoracic false lumen, enlargement of the true lumen,covering the left subclavian artery. The covered portion of the aorta tapered from 21 to 19 mm in diameter. C, An anteroposterior chest radiograph on post-
operative day 3 showed distortion of the proximal aspect of the device. D, Axial image from a contrast medium–enhanced computed tomographic scan con-
firmed collapse of the stent graft. E, Real-time fluoroscopic imaging revealed dynamic collapse varying in severity according to the cardiac cycle. The collapse
was repaired by using 2 balloon-expandable stents in the proximal and mid portions of the stent graft. F, Right anterior oblique spot image of the repaired
device showed restoration of the circular cross-section. Note the residual redundancy of the distal gold ring, which is indicative of incomplete expansion from
constraint within an undersized vessel.rgery c August 2009
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DFIGURE 2. A, Curved planar reconstruction of a computed tomographic angiogram performed on a 42-year-old man 20 days after onset of back, flank, and
abdominal pain; anorexia; and increased hypertension showed a type B dissection with nearly complete obliteration of the aortic true lumen. The undissected
arch measured 31 mm in diameter. The dissection flap extended into the left subclavian artery. B, Lateral chest radiograph 3 days after deployment of a 34 mm
3 15 cm TAG over the primary intimal tear and covering the left subclavian artery showed incomplete expansion of the distal portion of the device, which was
not recognized at the time of deployment. C, Posterior view maximum-intensity projection of the postprocedural computed tomographic angiogram demon-
strated the seam of infolding extending along the distal 9 cm with a crescentic cross-section at the level of the distal gold band. A complex endoleak was
observed involving the proximal landing area and the left subclavian artery. D, Lateral chest radiograph 3 months after coil embolization of the origin of
the left subclavian artery showed coils extending into the false lumen of the aorta (hollow arrow) across the portion of the primary intimal tear extending
into the left subclavian artery (solid arrow), the source of a complex endoleak. The midportion of the device showed interval expansion caused by the throm-
bosis and relief of pressurization of the false lumen in the proximal descending thoracic aorta (arrowheads), but the distal infolding remained. E, Lateral chestThe Journal of Thoracic and Cardiovascular Surgery c Volume 138, Number 2 329
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DFIGURE 3. A, Curved planar reconstruction of a computed tomographic angiogram performed on a 67-year-oldman after stent graft repair of an anastomotic
pseudoaneurysm 47 years after open repair of an aortic coarctation showed incomplete apposition of the device to the medial lesser curvature of the aorta at the
level of a kink. The medial aspect of the stent graft protruded into the arch by 21 mm (arrow), even though the lateral aspect was well apposed because of
a sharp angulation in the aorta. An intraoperative type Ia endoleak necessitated 2 proximal extensions, successfully excluding the pseudoaneurysm but result-
ing in this ‘‘bird beak.’’ B, Follow-up computed tomographic angiography imaging 6 years later showed collapse of the most proximal stent graft, with throm-
bus accumulated within the collapsed lumen, blood flow external to the collapsed device, and complete thrombosis and resorption of the pseudoaneurysm. The
patient remains asymptomatic and has declined reintervention.and spontaneous unfolding of the collapsed endograft at 21
months. However, an ulcer formed at the distal end of the
stent graft, evidently from erosion through the flap into the
false lumen. At 31 months, the patient presented with mild
hemoptysis believed to be due to left upper lobe adhesion
to the aorta. The patient underwent open surgical partial ex-
plantation, graft repair, and lysis of adhesions to the lung but
died on postoperative day 4 from complications of postoper-
ative ventricular fibrillation arrest.
Patient 6
A 67-year-old asymptomatic man was given a diagnosis
of an enlarging pseudoaneurysm by means of echocardio-
graphic imaging after having undergone surgical repair of
aortic coarctation and ventricular septal defect at age 20
years. He was enrolled in the 03-03 Pivotal Gore trial,
although with a protocol deviation because of his prior
operation. The distal aortic arch was severely kinked, with
a diameter at the kink of 24 3 18 mm. The 2 Thoracic
Excluder devices originally deployed did not create an
adequate proximal seal. Two successive extensions were330 The Journal of Thoracic and Cardiovascular Sudeployed to achieve a better proximal seal. The most proxi-
mal of these, a 26 mm3 7.5 cm device, jutted into the kink,
where the proximal device was constrained to a diameter of
24 3 18 mm. In addition, a 21-mm length of the proximal
device did not appose the lesser curvature (Figure 3).
The sac was successfully excluded, and the patient re-
mained asymptomatic as the pseudoaneurysm diminished
in size. A follow-up CT scan performed 79 months after
endograft repair showed complete collapse of the proximal
device with well-maintained distal perfusion. A moderate
amount of thrombus was detected within the residual lumen
of the collapsed device. Because of a lack of symptoms, the
patient did not wish to undergo further procedures but under-
went follow-up CT scans 13 and 21 months later, which
showed no change. The aortic diameter has decreased
from 79 to 39 mm, and the aneurysmal sac has decreased
from 56 to 9 mm in diameter. Resting ankle brachial indices
were 0.8 bilaterally, with no significant change after exer-
cise. With continued lack of symptoms and a high predicted
risk of distal embolization with manipulation of the col-
lapsed stent, no further interventions have been performed.radiograph taken 3 months after coil embolization of the right T8 intercostal artery showed complete expansion of the entire stent graft. F, Computed tomo-
graphic angiographic imaging also showed complete thrombosis and regression of the false lumen at the level of the stent graft, although with a focal erosion
through the intimal flap causing an ulcer-like excavation into the false lumen at the distal end of the stent graft (arrow). The infradiaphragmatic false lumen
remained patent from flow through natural fenestrations (asterisk).rgery c August 2009
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Since the introduction of the redesigned Gore thoracic en-
doprosthesis in 2003, the subtle engineering modifications
have manifested as equally subtle changes in clinical perfor-
mance.15 Although the observation of longitudinal spine
fractures, as was observed in the preceding Thoracic Ex-
cluder device, was completely eliminated by elimination
of the spine altogether, the newer TAG device appears sus-
ceptible to other mechanical events, including partial or total
collapse. Recognition of this potentially catastrophic event
has heightened the awareness of the specific guidelines in
the Instructions for Use (IFU)1 and has spread a message
of caution to those interested in potential off-label applica-
tion of the device. All 6 of the collapses described here
involved patients enrolled in protocols addressing indica-
tions other than aneurysms, the indication for which the
device is currently approved.
At least 22 incidents of TAG collapse have appeared in
the literature (Table 4),2-12 most of which occurred in pa-
tients treated for blunt traumatic injury. The emerging con-
sensus in the literature is that the major risk for collapse is
use in a small-diameter aorta outside of the recommenda-
tions specified in the IFU. Steinbauer and colleagues11 re-
futed this but in fact misquoted the IFU as allowing
‘‘oversizing of 25%,’’ which is inaccurate for the small-
est-diameter devices (26 and 28 mm diameter), which allow
for only 13% and 16% oversizing. Muhs and associates8
found that minimum aortic diameter and distal landing
zone diameter were the only 2 variables that predicted col-
lapse. Other suspected factors, including arch curvature
and length of lack of apposition, did not reach statistical sig-
nificance, although small sample size limited conclusions.
One of our patients, even in retrospect, had aortic dimen-
sions just within the IFU specifications but had incomplete
apposition proximally in the acutely curved distal arch,
suggesting some contribution from difficult geometry and
imperfect apposition. Regardless of the pathology being
treated, these data highlight the importance of heeding the
anatomic inclusion criteria specified by the manufacturer.
Gore’s own comprehensive system of reporting has identi-
fied a total of 95 device compressions resulting in 2 device-
related deaths of a total of 25,000 devices distributed
worldwide.16 Each of these identified cases has undergone ret-
rospective failure analysis, including meticulous remeasure-
ment of aortic anatomic dimensions by using 3-dimensional
reconstructions. They concluded that the root cause of com-
pression is multifactorial, with the highest reported incidence
in young patients presenting with acute traumatic transection.
These patients generally had aortic diameters of less than 23
mm, had tight radii of curvature of the aortic arch, and would
be expected to have peak blood flow velocities and aortic wall
elastic pulsatility values significantly greater than in older pa-
tients with degenerative, atherosclerotic aneurysmal disease.The Journal of Thoracic andIn addition, the TAG device was originally designed and
subsequently approved by the FDA to treat aneurysms,
where the intervening aorta between the 2 landing zones is
likely to be larger in diameter than either landing zone.
This anatomic configuration is unlikely to be true in the
cases of blunt traumatic transections and aortic dissections,
the pathologies most frequently associated with endograft
collapse. Additional measurements of aortic dimensions
along the entire length of the endografted aorta, as well as
estimation of the compliance of the disrupted wall or dissec-
tion flap, might need to be factored into procedural planning
in these patient populations. In fact, the 2 ‘‘collapses’’ in our
patients undergoing dissection were actually incomplete
expansions from the time of deployment and not delayed
collapses of fully expanded devices.
Controversy still remains about how best to treat smaller-
diameter aortas, many of which are afflicted by pathologies
other than degenerative aneurysms. For patients in whom
conventional open surgical intervention is prohibitively
risky, other endovascular options can be considered, al-
though data are limited. Options include using endografts
of smaller diameter, such as abdominal aortic or iliac compo-
nents, or the Medtronic Talent Thoracic device (Medtronic,
Minneapolis, Minn), which is available to treat aortas as
small as 22 mm. Alternatively, radial hoop strength can be
increased by using devices from other manufacturers (Talent
and Zenith TX2 [Cook Medical, Inc, Bloomington, Ind],
available down to 28 mm in diameter), by prophylactically
placing balloon-expandable stents, or by prophylactically
deploying 2 superimposed TAG devices.
The clinical complications resulting from collapse vary
widely in the literature, from recurrent aneurysm perfusion
and distal ischemia caused by aortic occlusion to complete
lack of symptoms. Our series of patients similarly presented
with signs and symptoms ranging from the life-threatening
to the unnoticeable. In addition, 2 of our collapses occurred
in the perioperative period in severely injured patients, in
whom more subtle signs and symptoms of endograft col-
lapse might have been masked amid the more dramatic se-
quelae of the original injury. One of our patients (and
perhaps one in the series published byMuhs and associates8)
has a collapse so severe that no symptoms are evident and
adequate perfusion of distal beds appears to be through an
effective ‘‘false lumen’’ outside of the collapsed endograft.
Thus, collapse is not necessarily catastrophic and might not
even warrant correction in some patients.
Whenwarranted, repair of collapse can be accomplished by
means of any of a variety of percutaneous or surgicalmethods.
Several reported patients underwent explantation and surgical
repair, which has the benefits of known durability and impos-
sibility of recurrent collapse. Thoracotomy, even in a patient
who has recovered from an initial aortic catastrophe, still car-
ries substantial morbidity and mortality. Especially in theCardiovascular Surgery c Volume 138, Number 2 331
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nd coworkers12 30 Transection 1 TAG NS NS
ecified.
Sze et al Acquired Cardiovascular Disease
A
C
Dpatient who has not yet recovered from concurrent injuries
or comorbidities, percutaneous methods are appealing. Re-
expansion of an endograft with a large balloon, although
effective in one of the patients in the series byMuhs and asso-
ciates,8 still carries a risk of recurrence. In the same patient
reported by Idu and coworkers6 and Hoornweg and col-
leagues,5 in one of the patients reported by Orend and
coworkers,10 and in one of our patients, recurrence was
directly observed under fluoroscopic or transesophageal echo-
cardiographic imaging within seconds after deflation of the
balloon. Placement of a reinforcing bare stent or stents confers
some additional security but requires larger femoral arterial
access. Furthermore, it is still no guarantee against recurrence
because 1 patient in the series reported by Muhs and col-
leagues8 suffered a recurrent collapse, even after the TAG
had been re-expanded and reinforced with a Palmaz stent.
A previously unreported phenomenon seen in our series is
the incompletely expanded device that was coaxed to ex-
pand spontaneously without further balloon dilatation or
supplemental stenting. In this patient with a subacute dissec-
tion, false lumen depressurization and thrombosis was
achieved by means of coil embolization of the covered
LSCA and a large intercostal artery, allowing the true lumen
to enlarge and to accommodate expansion of the TAG. All
reinterventions in this patient were done through 5F arterial
sheaths and without general anesthesia. However, the final
unfolding of the device apparently eroded through the dis-
section flap and formed an ulcer.
Our case of the delayed collapse of an original Thoracic
Excluder is also unlike the other reported cases. Although
retrospective analysis of the kinking of the aorta, the over-
sizing of the device, and the lack of apposition of the leading
lip of the device help to explain the collapse, its occurrence
more than 6 years after successful exclusion of a pseudoa-
neurysm is troubling. The device achieved its original
goal of eliminating the aneurysm so well that the geometry
of the aorta became less suitable for device integrity, result-
ing in a spine fracture and collapse. Unfortunately, this
reinforces admonitions from skeptics who raise concerns
about the durability of endograft repairs. As this technologyThe Journal of Thoracic and Cis applied to younger patients with longer life expectancies,
lifelong surveillance becomes a more challenging task.
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